Related references
Note: Only part of the references are listed.Implications of nanotechnology for the treatment of cancer: Recent advances
Sergey G. Klochkov et al.
SEMINARS IN CANCER BIOLOGY (2021)
Nanodelivery Systems for Topical Management of Skin Disorders
Mingyue Cui et al.
MOLECULAR PHARMACEUTICS (2021)
Tumor protein p53 mutation in archived tumor samples from a 12-year survivor of stage 4 pancreatic ductal adenocarcinoma may predict long-term survival with DeltaRex-G: A case report and literature review
Michael Morse et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
Nanomaterials arising amid antibiotic resistance
Weiwei Gao et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Novel Experience in Hybrid Tracers Clinical Evaluation of Feasibility and Efficacy in Using ICG-99mTc Nanotop for Sentinel Node Procedure in Breast Cancer Patients
Gianpiero Manca et al.
CLINICAL NUCLEAR MEDICINE (2021)
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
David Adams et al.
LANCET NEUROLOGY (2021)
Inducing immune tolerance with dendritic cell-targeting nanomedicines
Anna Cifuentes-Rius et al.
NATURE NANOTECHNOLOGY (2021)
Exosome-based candidates move into the clinic
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2021)
Extracellular vesicles versus synthetic nanoparticles for drug delivery
Kenneth W. Witwer et al.
NATURE REVIEWS MATERIALS (2021)
Oxygen-Delivering Polyfluorocarbon Nanovehicles Improve Tumor Oxygenation and Potentiate Photodynamic-Mediated Antitumor Immunity
Zhiwan Wang et al.
ACS NANO (2021)
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Exosome-based liquid biopsies in cancer: opportunities and challenges
W. Yu et al.
ANNALS OF ONCOLOGY (2021)
A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system
Alexandros Marios Sofias et al.
DRUG DISCOVERY TODAY (2021)
Inclisiran: First Approval
Yvette N. Lamb
DRUGS (2021)
Current strategies for oral delivery of BCS IV drug nanocrystals: challenges, solutions and future trends
Yue Wang et al.
EXPERT OPINION ON DRUG DELIVERY (2021)
Mutational and biophysical robustness in a prestabilized monobody
Peter G. Chandler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Nanomedicines accessible in the market for clinical interventions
Vedant Gadekar et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Kai Wu et al.
VACCINE (2021)
Targeted drug delivery strategies for precision medicines
Mandana T. Manzari et al.
NATURE REVIEWS MATERIALS (2021)
Cell therapies in the clinic
Lily Li-Wen Wang et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)
Engineering a Second-Order DNA Logic-Gated Nanorobot to Sense and Release on Live Cell Membranes for Multiplexed Diagnosis and Synergistic Therapy
Dan Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Delivery routes matter: Safety and efficacy of intratumoral immunotherapy
Emily De Lombaerde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
Takeshi Ishikawa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
The progress and perspective of strategies to improve tumor penetration of nanomedicines
Jiang Hu et al.
CHINESE CHEMICAL LETTERS (2021)
Antibody-Drug Conjugates-A Tutorial Review
Stephanie Baah et al.
MOLECULES (2021)
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Prabhu S. Arunachalam et al.
NATURE (2021)
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi et al.
VACCINES (2021)
Nanobodies for Medical Imaging: About Ready for Prime Time?
Lea Berland et al.
BIOMOLECULES (2021)
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
Su Chul Jang et al.
COMMUNICATIONS BIOLOGY (2021)
Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
Xin Luan et al.
BIOMATERIALS (2021)
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson et al.
CLINICAL CANCER RESEARCH (2021)
Loncastuximab Tesirine: First Approval
Arnold Lee
DRUGS (2021)
Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation
Paul-Michel Mertes et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Obstacles and opportunities in a forward vision for cancer nanomedicine
Irene de Lazaro et al.
NATURE MATERIALS (2021)
A first step toward in vivo gene editing in patients
Hildegard Buening et al.
NATURE MEDICINE (2021)
Extracellular vesicles as a next-generation drug delivery platform
Inge Katrin Herrmann et al.
NATURE NANOTECHNOLOGY (2021)
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D. Gillmore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance
Yongheng Wang et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19
Arjun Sharma et al.
FRONTIERS IN MEDICINE (2021)
Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review
Cynthia Bender et al.
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification
Jessica Jou et al.
CLINICAL CANCER RESEARCH (2021)
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study (vol 20, pg 49, 2021)
D. Adams et al.
LANCET NEUROLOGY (2021)
Targeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor
Tao Tan et al.
ACTA PHARMACEUTICA SINICA B (2020)
The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases
Maarten L. J. Smits et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Enhancing Triple Negative Breast Cancer Immunotherapy by ICG-Templated Self-Assembly of Paclitaxel Nanoparticles
Bing Feng et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
Alice Avancini et al.
ONCOLOGIST (2020)
Can postoperative dexamethasone nanoparticle eye drops replace mitomycin C in trabeculectomy?
Gauti Johannesson et al.
ACTA OPHTHALMOLOGICA (2020)
Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy
Shrawani Lamichhane et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Trends in Therapeutic Conjugates: Bench to Clinic
Arnab Rudra et al.
BIOCONJUGATE CHEMISTRY (2020)
Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial
Jong-Chan Lee et al.
GASTROINTESTINAL ENDOSCOPY (2020)
Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy
Hong Wang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals
Zhi Zhang et al.
JOURNAL OF SEPARATION SCIENCE (2020)
Antibody drug conjugates: Development, characterization, and regulatory considerations
Nagavendra Kommineni et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2020)
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab A Phase 2 Clinical Trial
Ciara M. Kelly et al.
JAMA ONCOLOGY (2020)
Extracellular vesicles as drug delivery systems: Why and how?
Omnia M. Elsharkasy et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy
Quan Zhou et al.
BIOMATERIALS (2020)
Intelligent micro-/nanorobots as drug and cell carrier devices for biomedical therapeutic advancement: Promising development opportunities and translational challenges
Vibhuti Agrahari et al.
BIOMATERIALS (2020)
CX-2029, a PROBODY drug conjugate targeting CD71 (transferrin receptor): Results from a first-in-human study (PROCLAIM-CX-2029) in patients (Pts) with advanced cancer.
Melissa Lynne Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance
Piyush P. Mehta et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
THREE DECADES OF ULTRASOUND CONTRAST AGENTS: A REVIEW OF THE PAST, PRESENT AND FUTURE IMPROVEMENTS
Peter Frinking et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2020)
Active transcytosis and new opportunities for cancer nanomedicine
Subehndu Pandit et al.
NATURE MATERIALS (2020)
Translational Nanomedicine Boosts Anti-PD1 Therapy to Eradicate Orthotopic PTEN-Negative Glioblastoma
Hiroaki Kinoh et al.
ACS NANO (2020)
Liposomes: Advancements and innovation in the manufacturing process
Sanket Shah et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Translational considerations in nanomedicine: The oncology perspective
Alberto A. Gabizon et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration
Peter Hnik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Improving the Treatment of Acute Lymphoblastic Leukemia
Ashish Radadiya et al.
BIOCHEMISTRY (2020)
Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed
Lei Fang et al.
SCIENCE ADVANCES (2020)
The progress and perspective of nanoparticle-enabled tumor metastasis treatment
Wei Zhang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Phospholipid membrane-decorated deep-penetrated nanocatalase relieve tumor hypoxia to enhance chemo-photodynamic therapy
Junjing Yin et al.
ACTA PHARMACEUTICA SINICA B (2020)
Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined
Huan Wang et al.
ACS NANO (2020)
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
Susannah L. Hewitt et al.
CLINICAL CANCER RESEARCH (2020)
Two-miRNA-based finger-stick assay for estimation of absorbed ionizing radiation dose
Marshleen Yadav et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery
F. J. Voskuil et al.
NATURE COMMUNICATIONS (2020)
Aspartate β-hydroxylase as a target for cancer therapy
Madiha Kanwal et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
A framework for designing delivery systems
Wilson Poon et al.
NATURE NANOTECHNOLOGY (2020)
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
Beate Schultheis et al.
CANCERS (2020)
Progress, challenges, and future of nanomedicine
Chenyang Zhang et al.
NANO TODAY (2020)
A phase 1/2, open-label, multicenter, dose escalation and efficacy study of mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding human OX40L, for intratumoral injection alone or in combination with durvalumab for patients with advanced malignancies
Antonio Jimeno et al.
CANCER RESEARCH (2020)
Emerging antibacterial nanomedicine for enhanced antibiotic therapy
Shuting Wang et al.
BIOMATERIALS SCIENCE (2020)
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls et al.
CELL (2020)
Sustainable technologies for liposome preparation
Maja Leitgeb et al.
JOURNAL OF SUPERCRITICAL FLUIDS (2020)
Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
Julia Paik et al.
DRUGS (2019)
Clinical cancer nanomedicine
Joy Wolfram et al.
NANO TODAY (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Alessandra Lopes et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy
Quan Zhou et al.
NATURE NANOTECHNOLOGY (2019)
Prolonged Release and Functionality of Interleukin-10 Encapsulated within PLA-PEG Nanoparticles
Skyla A. Duncan et al.
NANOMATERIALS (2019)
Advanced Nanotechnology Leading the Way to Multimodal Imaging-Guided Precision Surgical Therapy
Cong Wang et al.
ADVANCED MATERIALS (2019)
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
Bo Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Antibody-drug conjugates for cancer
Cindy H. Chau et al.
LANCET (2019)
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2-3, randomised, controlled trial
Sylvie Bonvalot et al.
LANCET ONCOLOGY (2019)
Current outlook on radionuclide delivery systems: from design consideration to translation into clinics
Oleksii O. Peltek et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration
Kirsten Lee Fetah et al.
SMALL (2019)
Engineered T Cell Therapy for Cancer in the Clinic
Lijun Zhao et al.
FRONTIERS IN IMMUNOLOGY (2019)
Nanomedicines Lost in Translation
Keegan Guidolin et al.
ACS NANO (2019)
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
Fatemeh Farjadian et al.
NANOMEDICINE (2019)
Recent advances in nanosized drug delivery systems for overcoming the barriers to anti-PD immunotherapy of cancer
Xiaochen Liu et al.
NANO TODAY (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases
Dadi A. Srinivasarao et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2019)
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
Olga M. Kutova et al.
CANCERS (2019)
MSLN-TTC (BAY 2287411) induces immunogenic cell death and secretion of pro inflammatory cytokines in vitro and triggers an immune memory effect against a mouse tumor model
Urs B. Hagemann et al.
CANCER RESEARCH (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
The Current State of Topical Burn Treatments: a Review
Danielle LaSalle Hashmi et al.
CURRENT TRAUMA REPORTS (2019)
Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist
Damien Carignan et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
Dongfei Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Block Copolymer Micelles in Nanomedicine Applications
Horacio Cabral et al.
CHEMICAL REVIEWS (2018)
Dendrimers in combination with natural products and analogues as anti-cancer agents
Serge Mignani et al.
CHEMICAL SOCIETY REVIEWS (2018)
Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Min Liang
CURRENT CANCER DRUG TARGETS (2018)
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities
Vibhuti Agrahari et al.
DRUG DISCOVERY TODAY (2018)
Can early intervention with pharmacotherapy reduce the morbidity and mortality of chronic lymphocytic leukemia?
Shuo Ma et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Immunoliposomes in clinical oncology: State of the art and future perspectives
Maria Merino et al.
JOURNAL OF CONTROLLED RELEASE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Harnessing albumin as a carrier for cancer therapies
Ella N. Hoogenboezem et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Rational Design of Nanoparticles with Deep Tumor Penetration for Effective Treatment of Tumor Metastasis
Zhiwen Zhang et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Pharmacologic profile of INT-1B3: A novel synthetic microRNA 193a-3p mimic for therapeutic intervention in oncology
Sanaz Yahyanejad et al.
CANCER RESEARCH (2018)
Quality by design (QbD) approaches in current pharmaceutical set-up
Vijay Mishra et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Alnylam launches era of RNAi drugs
Ken Garber
NATURE BIOTECHNOLOGY (2018)
Porous Gold Nanoshells on Functional NH2-MOFs: Facile Synthesis and Designable Platforms for Cancer Multiple Therapy
Chuang Liu et al.
SMALL (2018)
Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy
Ahmad Al-Shihabi et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Praveen K. Bommareddy et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Recent advances of bispecific antibodies in solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
DNA-Containing Exosomes Derived from Cancer Cells Treated with Topotecan Activate a STING- Dependent Pathway and Reinforce Antitumor Immunity
Yuichi Kitai et al.
JOURNAL OF IMMUNOLOGY (2017)
Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
Arman Jahangiri et al.
JOURNAL OF NEUROSURGERY (2017)
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
Christopher J. Genito et al.
VACCINE (2017)
Application of quality by design in the current drug development
Lan Zhang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Oncolytic viral Therapy for Mesothelioma
Daniel F. Pease et al.
FRONTIERS IN ONCOLOGY (2017)
Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma
Wendy K. Nevala et al.
SCIENTIFIC REPORTS (2017)
Safety and Toxicological Considerations of Nanomedicines: The Future Directions
Parmi Patel et al.
CURRENT CLINICAL PHARMACOLOGY (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Transport of drugs from blood vessels to tumour tissue
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2017)
Bioengineering bacterial outer membrane vesicles as vaccine platform
Matthias J. H. Gerritzen et al.
BIOTECHNOLOGY ADVANCES (2017)
NG-348: a novel oncolytic virus designed to mediate anti-tumour activity via the potent and selective polyclonal activation of tumor-infiltrating T-cells
Brian R. Champion et al.
CANCER RESEARCH (2017)
Liposomes for Pulmonary Drug Delivery: The Role of Formulation and Inhalation Device Design
Abdelbary Elhissi
CURRENT PHARMACEUTICAL DESIGN (2017)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products
Greg Troiano et al.
AAPS JOURNAL (2016)
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma
Donald D. Rao et al.
MOLECULAR THERAPY (2016)
Bankruptcy of nanomedicine firm worries drug developers
Heidi Ledford
NATURE (2016)
A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation
Paul Spearman et al.
VACCINE (2016)
Peptide-based synthetic vaccines
Mariusz Skwarczynski et al.
CHEMICAL SCIENCE (2016)
Drug-loaded erythrocytes: on the road toward marketing approval
Vanessa Bourgeaux et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma
Abdul Shukkur Ebrahim et al.
ONCOTARGET (2016)
Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids
Gregory S. Hamilton
BIOLOGICALS (2015)
Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
Douglas B. Johnson et al.
IMMUNOTHERAPY (2015)
Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases
Krystal Archer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles
Dilip Y. Paithankar et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Surface chemistry and serum type both determine the nanoparticle-protein corona
Daniela Pozzi et al.
JOURNAL OF PROTEOMICS (2015)
A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
Benjamin J. Solomon et al.
PLOS ONE (2015)
Radioimmunotherapy of human tumours
Steven M. Larson et al.
NATURE REVIEWS CANCER (2015)
Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer
Jong-Min Lim et al.
ACS NANO (2014)
SURVIVAL EFFICACY OF THE PEGYLATED G-CSFs MAXY-G34 AND NEULASTA IN A MOUSE MODEL OF LETHAL H-ARS, AND RESIDUAL BONE MARROW DAMAGE IN TREATED SURVIVORS
Hui Lin Chua et al.
HEALTH PHYSICS (2014)
Respirable nanocarriers as a promising strategy for antitubercular drug delivery
Mohammed M. Mehanna et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Issues and concerns in nanotech product development and its commercialization
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Novel Nano-Sized MR Contrast Agent Mediates Strong Tumor Contrast Enhancement in an Oncogene-Driven Breast Cancer Model
Per-Olof Eriksson et al.
PLOS ONE (2014)
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
Jonathan E. Zuckerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Evan Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Inhaled liposomal amikacin
Valerie Waters et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2014)
Future of the Particle Replication in Nonwetting Templates (PRINT) Technology
Jing Xu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
18F-FLT-PET/CT for the prediction of response to ANG-1005 therapy in patients with brain metastases from breast cancer
L. Amiri-Kordestani et al.
CANCER RESEARCH (2013)
Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer
Marije Slingerland et al.
CLINICAL THERAPEUTICS (2013)
Discontinued drugs in 2011: oncology drugs
Robert Williams
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia
John P. Bullivant et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results
Joseph M. Herman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
Shinichi Kageyama et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Albumin-based nanoparticles as potential controlled release drug delivery systems
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma
Masafumi Shimoda et al.
JOURNAL OF HEPATOLOGY (2012)
Very Small Size Proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer
Franklin Fuentes Aguilar et al.
VACCINE (2012)
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma
Marta Osorio et al.
Cancer Management and Research (2012)
Liposomal preparation by supercritical fluids technology
J. Zhong et al.
AFRICAN JOURNAL OF BIOTECHNOLOGY (2011)
Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11
Mark Matijevic et al.
CELLULAR IMMUNOLOGY (2011)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Teni Boulikas
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers
Hong Zhao et al.
BIOCONJUGATE CHEMISTRY (2008)
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
Corey J. Langer et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
J. S. Powell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model
Mariano R. Gabri et al.
CLINICAL CANCER RESEARCH (2006)
Contrast-Enhanced EUS (CE-EUS) Using a New Microbubble Contrast Agent (MRX-815) - A Feasibility Study in a Porcine Model
Robert F. Wong et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice
K Zhang et al.
CLINICAL CANCER RESEARCH (2005)
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Fp-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor
J Neidhart et al.
VACCINE (2004)
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma
J Voges et al.
ANNALS OF NEUROLOGY (2003)
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P Reimer et al.
EUROPEAN RADIOLOGY (2003)
Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial
MD Prados et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Share Paper
